PRE-FUNDED COMMON STOCK PURCHASE WARRANT applied dna sciences, inc.Security Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York
Contract Type FiledOctober 1st, 2025 Company Industry JurisdictionTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_______________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the later of (i) the date that Stockholder Approval (as defined in the Purchase Agreement) is obtained and (ii) the date that the Subscription Amount (as defined in the Purchase Agreement) is delivered in transferrable form reasonably acceptable to the Company with good and marketable title and is free and clear of any security interests, pledges, liens, restrictions, claims or encumbrances of any kind (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Commo
PRE-FUNDED COMMON STOCK PURCHASE WARRANT applied dna sciences, inc.Security Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York
Contract Type FiledOctober 1st, 2025 Company Industry JurisdictionTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_______________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES E-2 COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Security Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York
Contract Type FiledOctober 1st, 2025 Company Industry JurisdictionTHIS SERIES E-2 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the later of (i) the date that Stockholder Approval (as defined in the Purchase Agreement) is obtained and (ii) the date that the Subscription Amount (as defined in the Purchase Agreement) is delivered in transferrable form reasonably acceptable to the Company with good and marketable title and is free and clear of any security interests, pledges, liens, restrictions, claims or encumbrances of any kind (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as sub
COMMON STOCK PURCHASE WARRANT Silo Pharma, Inc.Security Agreement • October 1st, 2025 • Silo Pharma, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 1st, 2025 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is five (5) years from the effective date of a resale registration statement registering the resale by the Holder of all of the Warrant Shares issued and issuable upon exercise of this Warrant (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silo Pharma, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES E-1 COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Security Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York
Contract Type FiledOctober 1st, 2025 Company Industry JurisdictionTHIS SERIES E-1 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES E-1 COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Security Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York
Contract Type FiledOctober 1st, 2025 Company Industry JurisdictionTHIS SERIES E-1 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES E-1 COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Security Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York
Contract Type FiledOctober 1st, 2025 Company Industry JurisdictionTHIS SERIES E-1 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).